Copyright
©The Author(s) 2016.
World J Hepatol. Mar 18, 2016; 8(8): 401-410
Published online Mar 18, 2016. doi: 10.4254/wjh.v8.i8.401
Published online Mar 18, 2016. doi: 10.4254/wjh.v8.i8.401
Figure 2 Interleukin-1β exerts proliferative effects in primary murine hepatic stellate cells, while Anakinra reduces hepatic stellate cell proliferation in vitro.
The effects of IL-1β± the IL-1 receptor antagonist Anakinra on the proliferation of murine HSCs were tested in vitro. A and B: The effects on HSC proliferation were examined using the BrdU assay after stimulation of cells with vehicle, and IL-1β at 0.1 and 1 ng/mL in the presence and absence of Anakinra (2.5 μg/mL), respectively (samples from n = 6 donor animals, bP < 0.01; dP < 0.001; ANOVA). HSC: Hepatic stellate cells; IL-1: Interleukin-1; ANOVA: Analyses of variance.
- Citation: Reiter FP, Wimmer R, Wottke L, Artmann R, Nagel JM, Carranza MO, Mayr D, Rust C, Fickert P, Trauner M, Gerbes AL, Hohenester S, Denk GU. Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4-/- mouse model. World J Hepatol 2016; 8(8): 401-410
- URL: https://www.wjgnet.com/1948-5182/full/v8/i8/401.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i8.401